• Mon, December 12, 2022

by: WOPRAI

Ben Hendrix Maintained (ACHC) at Buy with Decreased Target to $93 on, Dec 12th, 2022

by: WOPRAI

Mark Massaro Initiated (BNGO) at Strong Buy and Held Target at $35 on, Dec 12th, 2022

by: WOPRAI

Swayampakula Ramakanth Initiated (AFMD) at Strong Buy and Held Target at $60 on, Dec 12th, 2022

by: WOPRAI

Daina Graybosch Maintained (AFMD) at Buy with Decreased Target to $60 on, Dec 12th, 2022

by: WOPRAI

Do Kim Maintained (AFMD) at Buy with Decreased Target to $60 on, Dec 12th, 2022

by: WOPRAI

James Shin Maintained (AFMD) at Buy with Decreased Target to $70 on, Dec 12th, 2022

by: WOPRAI

Dan Dolev Maintained (ADP) at Strong Buy with Increased Target to $285 on, Dec 12th, 2022

by: WOPRAI

Joseph Catanzaro Initiated (ACRV) at Buy and Held Target at $25 on, Dec 12th, 2022

by: WOPRAI

Akash Tewari Initiated (ACRV) at Strong Buy and Held Target at $17 on, Dec 12th, 2022

by: WOPRAI

Joseph Thome Initiated (ACRV) at Buy on, Dec 12th, 2022

by: WOPRAI

Tyler Radke Maintained (ADBE) at Hold with Decreased Target to $337 on, Dec 12th, 2022

by: WOPRAI

Karl Keirstead Maintained (ADBE) at Hold with Increased Target to $350 on, Dec 12th, 2022

by: WOPRAI

Christopher Rolland Initiated (ADI) at Buy and Held Target at $205 on, Dec 12th, 2022

by: WOPRAI

Joanne Wuensch Maintained (ZBH) at Hold with Increased Target to $130 on, Dec 12th, 2022

by: WOPRAI

Kate McShane Maintained (ASO) at Strong Buy with Increased Target to $65 on, Dec 12th, 2022

by: WOPRAI

Kristine Liwag Upgraded (CAE) to Buy on, Dec 12th, 2022

by: WOPRAI

Jordan Bender Downgraded (BYD) to Hold on, Dec 12th, 2022

by: WOPRAI

Jared Garber Downgraded (CAKE) to Strong Sell and Decreased Target to $29 on, Dec 12th, 2022

by: WOPRAI

Raghuram Selvaraju Maintained (URGN) at Strong Buy with Decreased Target to $23 on, Dec 12th, 2022

by: WOPRAI

Nicholas Joseph Maintained (WELL) at Hold with Decreased Target to $70 on, Dec 12th, 2022

by: WOPRAI

Andrew Obin Downgraded (VNT) to Hold on, Dec 12th, 2022

by: WOPRAI

Christopher Rolland Initiated (WOLF) at Hold and Held Target at $90 on, Dec 12th, 2022

by: WOPRAI

Kate McShane Maintained (WSM) at Strong Sell with Decreased Target to $55 on, Dec 12th, 2022

by: WOPRAI

Joseph Thome Initiated (XENE) at Buy on, Dec 12th, 2022

by: WOPRAI

Edward Tenthoff Initiated (XFOR) at Buy and Held Target at $3 on, Dec 12th, 2022

by: WOPRAI

Steve Fleishman Upgraded (SO) to Buy and Held Target at $76 on, Dec 12th, 2022

by: WOPRAI

Edward White Maintained (SNDX) at Strong Buy with Increased Target to $33 on, Dec 12th, 2022

by: WOPRAI

Madhu Kumar Maintained (SNDX) at Strong Buy with Increased Target to $39 on, Dec 12th, 2022

by: WOPRAI

Bert Subin Maintained (SNDR) at Strong Buy with Increased Target to $30 on, Dec 12th, 2022

by: WOPRAI

Julien Dumoulin-Smith Downgraded (SR) to Sell and Decreased Target to $61 on, Dec 12th, 2022

by: WOPRAI

Dan Dolev Maintained (SQ) at Hold with Increased Target to $70 on, Dec 12th, 2022

by: WOPRAI

Christopher Rolland Initiated (STM) at Buy and Held Target at $50 on, Dec 12th, 2022

by: WOPRAI

Larry Biegelsen Maintained (SYK) at Buy with Increased Target to $281 on, Dec 12th, 2022

by: WOPRAI

Peter Lawson Maintained (BPMC) at Hold with Decreased Target to $53 on, Dec 12th, 2022

by: WOPRAI

Pinjalim Bora Upgraded (BOX) to Buy and Increased Target to $34 on, Dec 12th, 2022

by: WOPRAI

Brooke Roach Maintained (BURL) at Strong Buy with Increased Target to $225 on, Dec 12th, 2022

by: WOPRAI

Raghuram Selvaraju Maintained (BWAY) at Strong Buy with Decreased Target to $13 on, Dec 12th, 2022

by: WOPRAI

Benjamin Chaiken Maintained (CCL) at Buy with Decreased Target to $19 on, Dec 12th, 2022

by: WOPRAI

Chandni Luthra Upgraded (CIGI) to Strong Buy and Increased Target to $119 on, Dec 12th, 2022

by: WOPRAI

Walter Spracklin Maintained (CSX) at Buy and Held Target at $35 on, Dec 12th, 2022

by: WOPRAI

Jason Gerberry Downgraded (ALLO) to Sell and Held Target at $9 on, Dec 12th, 2022

by: WOPRAI

Christopher Rolland Initiated (AMBA) at Buy and Held Target at $90 on, Dec 12th, 2022

by: WOPRAI

Adam Kramer Maintained (AMH) at Hold with Decreased Target to $32 on, Dec 12th, 2022

by: WOPRAI

Kristine Liwag Maintained (TDG) at Buy with Decreased Target to $765 on, Dec 12th, 2022

by: WOPRAI

Kristine Liwag Upgraded (TDY) to Hold and Increased Target to $488 on, Dec 12th, 2022

by: WOPRAI

Patrick Donnelly Upgraded (TECH) to Strong Buy and Increased Target to $100 on, Dec 12th, 2022

by: WOPRAI

Dan Dolev Maintained (UPST) at Sell with Increased Target to $14 on, Dec 12th, 2022

by: WOPRAI

Kate McShane Downgraded (ULTA) to Hold and Decreased Target to $508 on, Dec 12th, 2022

Joseph Catanzaro Initiated (ACRV) at Buy and Held Target at $25 on, Dec 12th, 2022

Joseph Catanzaro of Piper Sandler, Initiated "Acrivon Therapeutics, Inc." (ACRV) at Buy and Held Target at $25 on, Dec 12th, 2022.

Joseph, nor any peers, have made any analyst calls on ACRV in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Like: 👍